CGS-1
Chronic Pain (Radicular Pain)
Phase II/IIIActive, Recruiting
Key Facts
Indication
Chronic Pain (Radicular Pain)
Phase
Phase II/III
Status
Active, Recruiting
Company
About Canopy Growth
Canopy Growth's mission is to be a world-leading diversified cannabis and consumer packaged goods company, leveraging its scale and scientific research to deliver therapeutic and wellness products. Its key achievement was securing a landmark $4 billion investment from Constellation Brands in 2018, which fueled rapid expansion and established it as an early industry leader. Current strategy focuses on a rigorous 'Right-Sizing' plan to achieve profitability, divesting non-core assets like BioSteel, and advancing its cannabinoid-based clinical research programs through its Canopy Growth Science division.
View full company profile